natural glp-1 receptor agonists Crystal structure of the bound to a peptide agonist Frontiers | Future Perspectives on

Two of the most talked-about medications in this area are Mounjaro and Ozempicboth injectable treatments that have demonstrated impressive results in clinical studies

All authors approved the final manuscript

Efficacy of Weight-loss A recent systematic review and a meta-analysis by Wong et al (2025) found that GLP-1 receptor agonists induced an additional 4.45 kilogram of weight loss over placebo based on 47 randomized control trials with a cohort of 23,244 patients

The LEAN trial with liraglutide and a phase 2 trial of semaglutide in patients with non-alcoholic steatohepatitis (NASH) showed improvements in liver histology and reductions in hepatic inflammation markers

EMERGING TRENDS AND POTENTIAL PRACTICE IMPLICATIONS Research on GLP-1 agonists suggests that these medications may be effective treatments for conditions beyond diabetes and obesity, suggesting a broad potential impact on health care